openPR Logo
Press release

Anticoagulant Reversal Drugs Market: Growth Potential & Opportunity Outlook 2017 - 2025

04-02-2018 02:18 PM CET | Health & Medicine

Press release from: TMR - Research Report

/ PR Agency: TMR - Research Report
Anticoagulant Reversal Drugs Market: Growth Potential &

Bleeding complications is a common concern associated with the use of anticoagulation drugs. Anticoagulant reversal drugs act as antidote agents to neutralize the condition that involves bleeding complications; for example, an unplanned surgery, hemophilia, etc. Anticoagulation reversal drugs are also required to support the medical treatment for prevention and reduction of recurrent deep-vein venous thromboembolism (VTE). These drugs reduce the incidence of recurrent ischemic events in patients with coronary syndrome. Anticoagulant reversal drugs such as idarucizumab contain selective monoclonal antibodies which have high binding affinity and which act as an antidote to dabigatran. This also helps in the prevention of stroke in patients with non-valvular atrial fibrillation. Heparin overdose, hypoprothrombinemia, reversal of acquired coagulation factor deficiency, reversal of dabigatran anticoagulation and vitamin K deficiency are a few medical conditions associated with anticoagulant reversal drugs.

Read Report Overview:

Rise in the prevalence of gastrointestinal bleeding and platelet disorders is one of the major factors propelling the anticoagulant reversal drugs market. Moreover, several medical journals reveal that 1%–5% of patients taking factor Xa-inhibitors may experience spontaneous bleeding. This is one of the key factors driving the global anticoagulant reversal drugs market. However, certain limitations associated with these drugs such as contraindication in patients with severe renal or hepatic diseases and absence of specific reversal drugs are likely to hamper the anticoagulant reversal drugs market in the next few years.

Based on drug type, the global anticoagulant reversal drugs market can be segmented into vitamin K, idrucizumab, tranexamic acid, prothrombin complex concentrates, and others. The idrucizumab segment is likely to expand at a rapid pace during the forecast period. This can be attributed to increase in the incidence of gastrointestinal bleeding among geriatric population led by increase in the use of pradaxa (a kind of drug that acts as an anticoagulant agent). In terms of distribution channel, the market can be categorized into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment is likely to expand at a rapid pace during the forecast period, as several unplanned surgeries such as those in case of accident cases are performed in hospitals.

Download Brochure of Report:

In terms of region, the global anticoagulant reversal drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Rise in the incidence of von Willebrand disease (the most common inherited bleeding disorder caused by clotting proteins) in North America is the major factor driving the anticoagulant reversal drugs market in the region. Increase in the demand for the treatment of hemophilia and growing awareness about the effect of constant use of anticoagulant drugs (blood-thinner drugs) are likely to propel the market in Europe. Rise in the demand for therapies effective in reducing complications associated with blood disorders and increase in the prevalence of hemophilia in the region are major factors that drive the anticoagulant reversal drugs market in Asia Pacific. The insufficiency of vitamin K is most common among mothers and newborn babies, which leads to vitamin K deficiency bleeding, especially in countries of East Africa such as Uganda. The prevalence of insufficiency of vitamin K is increasing, which is one of the most important factors expected to boost the anticoagulant reversal drugs market in Middle East & Africa during the forecast period.

Request For Custom Research:

Key players operating in the global anticoagulant reversal drugs market are Boehringer Ingelheim Pharmaceuticals Inc., Valeant Pharmaceuticals International, Inc., Fresenius Kabi USA, and CSL Behring.

About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anticoagulant Reversal Drugs Market: Growth Potential & Opportunity Outlook 2017 - 2025 here

News-ID: 1000479 • Views:

More Releases from TMR - Research Report

Global Tissue Extraction System Market: Trends and Opportunities 2017 - 2025
Global Tissue Extraction System Market: Trends and Opportunities 2017 - 2025
Global Tissue Extraction System Market: Overview The global tissue extraction system market is foretold to display an impressive growth rate in the coming years. This could be owing to the need for tissue extraction or biopsy for cancer analysis after the patient has been suspected of carrying the disease. The procedure is extremely vital for diagnosing the disease. Thus, increasing prevalence of carcinogenic agents, compromised immunity levels, and rising incidence of
Neurology Sterile Injectable Market: Growth Factors, Applications, Regional Analysis 2017 - 2025
Neurology Sterile Injectable Market: Growth Factors, Applications, Regional Anal …
Neurology sterile injectables are generally administered to individuals suffering from pain linked to the nerves. Neuropathic pain injections are used to provide relief to these individuals. Neurology sterile injectable block the pain signal from reaching the brain. Neurological sterile injection can be administered at sympathetic nervous system, trigger points, dorsal roots, and peripheral nerves. The most commonly use neurological injectable used for nerve block are steroid injection, opioids, and local
External Fixator Devices Market: Global Survey and Trend Research
External Fixator Devices Market: Global Survey and Trend Research
External fixator devices are used to stabilize and support long bone open fractures to help the patient carry body’s weight as well as movement. Schanz screws, connecting rods, and clamps are used in case of unipolar external fixators. Circulatory fixators include circular rings, wires, connecting rods, and struts. The external fixator devices provide rigid fixation along with fixed distraction of the fracture fragments. The major advantage of external fixator devices
Anorectal Preparations Market Trends, and Forecast 2017 - 2025
Anorectal Preparations Market Trends, and Forecast 2017 - 2025
Anorectal preparations are products that contain a combination of an anti-inflammatory agent, or a pain reliever, and a local anesthetic as a suppository, or an ointment. External or internal hemorrhoids are treated by the topical application of anorectal preparations. Hemorrhoids are masses or lumps of tissue in the anus that contain enlarged blood vessels. The formation of hemorrhoids is due to an increase in abdominal pressure. Frequent constipation, which is

All 5 Releases

More Releases for Anticoagulant

Anticoagulant Treatment Market 2021 | Detailed Report
The Anticoagulant Treatment market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The Anticoagulant Treatment report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period. Download FREE Sample Report @ The Anticoagulant Treatment research report also provides
Anticoagulant Reversal Medicine Market global outlook and forecast 2021 -2027
The Global Anticoagulant Reversal Medicine Market research report is a careful examination of the worldwide industry which has been a region of enthusiasm for a Anticoagulant Reversal Medicine makers, organizations, authorities, chiefs, and likely speculators, and analysts. The report profoundly lights up noteworthy features in the business, including a contention situation, condition, portions, showcase size, share, gainfulness, development potential, and advancements. The report likewise
Anticoagulants Market To See Record Break Revenue $43.42 Million By 2025 | Vitam …
Anticoagulants are medicinal substances that reduce the coagulation of blood and prolong the clotting time. Anticoagulant drugs achieve their effects by suppressing the synthesis or function of various clotting factors that exist in the blood. The global anticoagulants market is anticipated to show significant market growth during the forecast period, owing to increase in prevalence of ischemic heart disease and venous thromboembolism (VTE) and awareness of novel oral anticoagulants (NOACs).
Anticoagulant Drugs Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Anticoagulant Drugs market. Click to view the full report TOC, figure and tables: Global Anticoagulant Drugs Market: Forecast by Type / Application / Region Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time. According to this study, over the next five years the Anticoagulant Drugs
Global Antithrombotic/Anticoagulant Drugs Technologies and Market Research Repor …
Researchmoz added Most up-to-date research on "Antithrombotic/Anticoagulant Drugs: Technologies and Global Markets" to its huge collection of research reports. The global market for antithrombotic/anticoagulant drugs should reach $27.3 billion by 2021 from $18.9 billion in 2016, a compound annual growth rate (CAGR) of 7.6%, from 2016 to 2021. The North American antithrombotic/anticoagulant drugs market is expected to grow from nearly $8.0 billion in 2016 to nearly $11.0 billion in 2021, a CAGR
Global Heparin Anticoagulant Market $11.5 Billion by 2021
The global heparin anticoagulant market is estimated to reach $11.5 Billion in 2021, growing at a CAGR of 4.4% from 2017 to 2021, according to a market research report Heparin Anticoagulant Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc. The global heparin anticoagulant market report provides market size (Revenue $Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021). The global heparin anticoagulant market